NLR, PLR, and SII Index May Predict Oncological Outcomes in Patients With Metastatic RCC Treated With Nivo+Ipi
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab
J Clin Med 2021 Nov 16;10(22)5325, K Iinuma, T Enomoto, K Kawada, S Fujimoto, T Ishida, K Takagi, S Nagai, H Ito, M Kawase, C Nakai, K Kawase, D Kato, M Takai, K Nakane, K Kameyama, T KoieFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.